Tango Therapeutics Inc (NASDAQ: TNGX) on Tuesday, soared 5.67% from the previous trading day, before settling in for the closing price of $7.93. Within the past 52 weeks, TNGX’s price has moved between $1.03 and $9.70.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 7.47%. The company achieved an average annual earnings per share of 27.00%. With a float of $78.40 million, this company’s outstanding shares have now reached $111.57 million.
Tango Therapeutics Inc (TNGX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tango Therapeutics Inc is 41.75%, while institutional ownership is 61.61%. The most recent insider transaction that took place on Oct 23 ’25, was worth 4,846,575. In this transaction 10% Owner of this company sold 477,401 shares at a rate of $10.15, taking the stock ownership to the 13,386,574 shares. Before that another transaction happened on Oct 23 ’25, when Company’s 10% Owner proposed sale 477,401 for $7.53, making the entire transaction worth $3,594,830.
Tango Therapeutics Inc (TNGX) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.34 earnings per share (EPS) for the period topping the consensus outlook (set at -0.34) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.06% during the next five years compared to 7.47% growth over the previous five years of trading.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
Tango Therapeutics Inc (TNGX) is currently performing well based on its current performance indicators. A quick ratio of 8.88 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.92, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
The latest stats from [Tango Therapeutics Inc, TNGX] show that its last 5-days average volume of 3.12 million was superior to 2.08 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 63.43%.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 74.12%, which indicates a significant increase from 62.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.77 in the past 14 days, which was higher than the 0.54 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.77, while its 200-day Moving Average is $4.64. Now, the first resistance to watch is $8.74. This is followed by the second major resistance level at $9.09. The third major resistance level sits at $9.59. If the price goes on to break the first support level at $7.89, it is likely to go to the next support level at $7.39. Assuming the price breaks the second support level, the third support level stands at $7.04.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
Market capitalization of the company is 1.13 billion based on 134,594K outstanding shares. Right now, sales total 42,070 K and income totals -130,300 K. The company made 53,810 K in profit during its latest quarter, and 15,880 K in sales during its previous quarter.
